About
Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyMidwest
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
69
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06159725Lead Sponsor
A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis
PHASE1/PHASE2Active, not recruiting
41 participants
Started: Jun 24, 2024 · Completed: Nov 30, 2025
NCT05629741Lead Sponsor
A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101
PHASE1Terminated
28 participants
Started: Nov 14, 2022 · Completed: Aug 2, 2024
Funding History (1)
D
Jan 19, 2024
Locations (1)
Headquarters
Columbus, OH, United States
Map
Loading map...